In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the degree of artemisinin resistance in adult and pediatric
subjects presenting with uncomplicated falciparum malaria in Western Kenya. The study
treatments will be Artemether Lumefantrine (AL) and Artesunate Mefloquine (ASMQ).
Phase:
Phase 4
Details
Lead Sponsor:
Global Emerging Infections Surveillance and Response System
Collaborators:
United States Army Medical Unit - Kenya Walter Reed Army Institute of Research (WRAIR)